This article contains content that is written like an advertisement .(May 2024) |
As we know brain tumour is a huge problem and it can be fatal if it is not cure .Over 300,000 cases reported across the world annually .this brain tumour can in turn into brain cancer so, we need to take a step to cure the brain tumour and for this we started research on brain tumour. Together we will find a cure.
Founded | 2009 |
---|---|
Founder | Sue Farrington Smith MBE |
Type | Charitable Organisation |
Purpose | Research and campaigning |
Headquarters | Suite 37, Shenley Pavilions, Chalkdell Drive, Shenley Wood, Milton Keynes, MK5 6LB |
Area served | United Kingdom |
Key people | Dan Knowles (Chief Executive), Sue Farrington Smith MBE |
Website | https://www.braintumourresearch.org/ |
Brain Tumour Research is a UK-based medical research charity dedicated to funding research, raising awareness of brain tumours. The charities vision is to find a cure for brain tumours of all kinds.
The charity works with and funds a network of experts in sustainable research at dedicated Centres of Excellence across the UK. [1] The charity also focuses on influencing the Government and larger cancer charities to invest more nationally.
In 2004, an informal partnership of several regional UK charities working to raise funds for brain tumour research and support agreed to join forces under the banner of the United Brain Tumour Campaign, committing themselves to work together to increase awareness across the UK and achieve a common goal to raise funds specifically for research in the UK into the prevention and treatment of brain tumours. [2]
The Diana Ford Trust, a charity funding brain tumour research, re-registered as Brain Tumour Research in 2008, using their cash deposits to fund first stage of a new national brain tumour research funding and awareness campaign. Brain Tumour Research was launched as a national charity in 2009. [3]
Brain Tumour Research also acts as an umbrella organisation for a number of brain tumour charities throughout the UK.
Brain Tumour Research is the only national brain tumour charity in the UK funding sustainable and continuous research into brain tumours at UK Centres of Excellence, in partnership with leading Universities and Healthcare bodies. These research centres are established through a rigorous and transparent application process including comprehensive international peer-review process.
Brain Tumour Research’s inaugural Centre is led by Professor Geoff Pilkington, a world renowned expert in Neuro-oncology. His team of specialist researchers within the Cellular and Molecular Neuro-Oncology Group are made up of a principal esearch fellow, research fellows, senior research associates and PhD students. Their team is strengthened with MSc and Erasmus students. They comprise the largest team of laboratory-based brain tumour research experts in the UK. [4] [5]
Research at the University of Portsmouth is also supported by funds being brought in by other charities, including Ali's Dream, Charlie's Challenge, Anna's Hope, Headcase, the Ollie Young Foundation, the Dr Hadwen Trust, and Children with Cancer.
Professor Silvia Marino, one of the UK’s leading neuropathologists, leads the Queen Mary University of London research team (in collaboration with UCL Institute of Neurology). Their research focuses on glioblastoma multiforme (GBM), the most common and most aggressive type of brain tumour found in humans. The researchers aim to increase understanding of the brain cells from which GBMs originate: how this tumour type develops from normal cells, and which genes and biological functions control its behaviour. By uncovering this knowledge, the clinical evaluation of each individual patient can be improved and specific drugs which target the tumour cells can be identified. [6]
Led by Mr Kevin O’Neill, a consultant neurosurgeon at Imperial College Healthcare NHS Trust, a team of world-class researchers are investigating the biology of tumour metabolisms to further understand the behaviour of this disease. [7]
Led by Professor Oliver Hanemann, the Plymouth University centre conducts research into low-grade brain tumours occurring in teenagers and adults. By identifying and understanding the mechanism that makes a cell become cancerous, the team explore ways in which to halt or reverse that mechanism. [8]
John Bercow, MP for Buckingham, Speaker of the House of Commons and Brain Tumour Research Patron established the first all-party parliamentary group (APPG) for brain tumours in July 2005.
The APPG is invaluable in promoting important messages about research to parliamentarians, raising awareness of brain tumours and influencing the national spend for research into this disease.
Members of the group attend parliamentary awareness raising events and meet three times a year to discuss relevant topics, and raise issues in the House of Commons through:
The group consists of MPs representing different political parties and the House of Lords.
The elected officers of the group (July 2017) are:
Previous elected officers of the group include:
Brain Tumour Research provides the secretariat for the Group.
Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.
Glioblastoma, previously known as glioblastoma multiforme (GBM), is the most aggressive and most common type of cancer that originates in the brain, and has a very poor prognosis for survival. Initial signs and symptoms of glioblastoma are nonspecific. They may include headaches, personality changes, nausea, and symptoms similar to those of a stroke. Symptoms often worsen rapidly and may progress to unconsciousness.
Parkinson's UK is a Parkinson's research and support charity in the United Kingdom. In April 2010, the Parkinson's Disease Society changed its name to become Parkinson's UK. Its aims are to improve the quality of life for people affected by Parkinson's and find a cure for the condition.
The Brain Tumour Charity is a UK-based, Charity Commission registered, charity dedicated to funding research, raising awareness of brain tumours, reducing diagnosis times and providing support and information for people with brain tumours, their families and friends.
Denise Sheer was appointed professor of human genetics at The Institute of Cell and Molecular Science at Queen Mary, University of London in November 2006. Her fields of expertise include cell and molecular biology; cancer genetics and epigenetics; and molecular pathology of paediatric brain tumours.
Paul Christopher Blomfield is a British politician who served as the Member of Parliament (MP) for Sheffield Central from 2010 to 2024. A member of the Labour Party, he was a Shadow Minister for Exiting the European Union from 2016 to 2020 and Shadow Minister for Brexit and European Union Negotiations from 2020 to 2021.
The Save A Brain Foundation was a 501(c)(3) non-profit organization with the goals of raising awareness of glioblastoma multiforme (GBM), the most common type of primary brain tumor, as well as raising money in hopes of finding a cure for this terminal disease. To date, the foundation has raised tens of thousands of dollars for brain cancer research.
John Philip Glen is a British politician and former management consultant who has served as Shadow Paymaster General since July 2024. A member of the Conservative Party, he has been the Member of Parliament (MP) for Salisbury in Wiltshire since 2010. Glen previously served in the Cabinet as Chief Secretary to the Treasury from 2022 to 2023, and as Minister for the Cabinet Office and Paymaster General from 2023 to 2024.
Diffuse midline glioma, H3 K27-altered (DMG) is a fatal tumour that arises in midline structures of the brain, most commonly the brainstem, thalamus and spinal cord. When located in the pons it is also known as diffuse intrinsic pontine glioma (DIPG).
The Edinburgh Cancer Research Centre (ECRC), also known as the University of Edinburgh Cancer Research Centre, is a center for basic, translational and clinical cancer research located in Edinburgh, Scotland. ECRC constitutes a part of the Institute of Genetics & Molecular Medicine (IGMM) and is positioned in direct proximity of the Western General Hospital, where most of its clinical activities take place.
The Robert Connor Dawes Foundation is an Australian not-for-profit organisation that facilitates funding in brain research, care and development in Australia and the United States. The foundation was created in June 2013 by Liz Dawes and Scott Dawes in memory of their son Robert Connor Dawes who died from a brain tumour in April 2013 at 18 years of age. As of July 31, 2015, they changed their name from Robert Connor Dawes Fund to Robert Connor Dawes Foundation.
The Queen Elizabeth Hospital Charity is a charity that was founded to support medical and health research, and to fund and encourage excellence in healthcare for patients and their caregivers, wholly or mainly through the services provided by University Hospital Birmingham NHS Foundation Trust. It raises money for campaigns that attempt to complement NHS services. The QEH Charity was formed in 2001, however, there has been an official charity associated with the Queen Elizabeth Hospital since the creation of the NHS in 1948. QEH became independent in April 2016.
Ren Michael Pedersen is an advocate for children's brain cancer research.
The Children's Cancer Foundation is a registered Australian charity that supports children with cancer and their families.
Sheila K. Singh MD, PhD, FRCSC is a chief pediatric neurosurgeon at McMaster Children's Hospital in Ontario, Canada. She is also Professor of Surgery and Biochemistry, the Division Head of Neurosurgery at Hamilton Health Sciences, the Research Director for McMaster's Division of Neurosurgery, and a scientist/principal investigator appointed to the Stem Cell and Cancer Research Institute at McMaster University.
Professor Richard James Gilbertson is a Senior Group Leader at the Cancer Research UK Cambridge Institute, University of Cambridge. He is the Li Ka Shing Chair of Oncology, and Director of the CRUK Cambridge Major Centre and the Children's Brain Tumour Centre of Excellence.
Michelle Leigh Monje-Deisseroth is a neuroscientist and neuro-oncologist. She is a professor of neurology at Stanford University and an investigator with the Howard Hughes Medical Institute. She develops new treatments for diffuse intrinsic pontine glioma.
Sarah Coupland is an Australian-born pathologist and professor who is the George Holt Chair in Pathology at the University of Liverpool. Coupland is an active clinical scientist whose research focuses on the molecular genetics of cancers, with particular interests in uveal melanoma, conjunctival melanoma, intraocular and ocular adnexal lymphomas and CNS lymphoma. Coupland is also an NHS Honorary Consultant Histopathologist at the Royal Liverpool University Hospital. Since 2006, Coupland has been head of the Liverpool Ocular Oncology Research Group; from which she runs a multidisciplinary oncology research group focussing on Uveal melanoma, based in the Department of Molecular and Clinical Cancer Medicine at the University of Liverpool. Her research laboratory is currently located in the Institute of Translational Medicine From April 2014 to December 2019, Coupland was also Director of the North West Cancer Research Centre, @UoL. In both 2019 and 2020, Coupland was included on the 'Pathology Powerlist' on The Pathologist website.
Jonathan Lester Finlay is a pediatric neuro-oncologist specializing in the management of children, adolescents and young adults with brain tumors. He is the director of Neuro-oncology at Nationwide Children's Hospital, where he also serves as the Elizabeth and Richard Germain Endowed Chair in Pediatric Cancer. He also is professor of pediatrics at The Ohio State University College of Medicine.
Rolando Fausto Del Maestro is an Italian-born Canadian neurosurgeon, the William Feindel Professor Emeritus in neuro-oncology and director of the Neurosurgical Simulation Research Center at the Montreal Neurological Institute and Hospital, where he has been involved in simulating real brain surgery by creating virtual setting scenarios, founded upon the principles of flight simulation.